Shiny K. Kajal/LinkedIn
Feb 5, 2026, 17:35
Shiny K. Kajal: ELISA vs CLIA vs NAT – Comparison of Screening Test for TTis
Shiny K. Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:
“ELISA vs CLIA vs NAT
Understanding the strengths of different screening assays is essential for ensuring blood safety. From conventional serological methods to advanced molecular testing, each technique plays a vital role in detecting transfusion-transmitted infections and reducing the window period.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters
-
Aug 14, 2026, 15:50John Strouse: Why Older Adults with Sickle Cell Disease Should Be Included in Clinical Trials
-
Aug 14, 2026, 15:44Scott Cameron: Understanding Sex Differences in Platelet Biology